Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
3-deoxy-D-arabino-heptulosonate 7-phosphate synthase (DAH7PS) is a key enzyme that catalyzes the first step in the shikimate pathway, which is essential for the biosynthesis of aromatic amino acids in bacteria, fungi, and plants but absent in animals. In *Helicobacter pylori*, DAH7PS is an essential protein and a promising novel drug target for the development of antibacterial therapies, particularly in the context of rising antibiotic resistance. Virtual screening and molecular dynamics studies have identified potential small molecule inhibitors, such as 6,8-dihydroxyisocoumarin-3-carboxylic acid and epicatechin, that bind stably to the enzyme and may serve as leads for future antimicrobial drug development. Further experimental validation is needed to confirm therapeutic efficacy and safety[1][2][3].
Enzyme inhibition (direct inhibition of DAH7PS enzyme activity)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase (DAH7PS).